merged_abortion-pill-ella.txt
<other>First, I will review the article to find the answers to the questions.</other>

<question_number>1</question_number>
<answer>0%</answer>
<other>The completion rate for both ulipristal acetate plus misoprostol and mifepristone plus misoprostol was similar, at 97%.</other>

<question_number>2</question_number>
<answer>N/A</answer>
<other>The article does not specify the dosage Dr. Gomperts prescribed in Europe.</other>

<question_number>3</question_number>
<answer>N/A</answer>
<other>The article does not mention any state's attorney general filing litigation challenging the use of Ella following the study's publication.</other>

<question_number>4</question_number>
<answer>0%</answer>
<other>The article states there were no serious complications reported in the study.</other>

<question_number>5</question_number>
<answer>N/A</answer>
<other>The article does not specify what should replace Ella in the required insurance coverage according to Project 2025's policy recommendations.</other>

<question_number>6</question_number>
<answer>N/A</answer>
<other>The article does not provide the exact number of days after the Supreme Court's decision when Dr. Winikoff began her research.</other>

<question_number>7</question_number>
<answer>To clarify that Plan B acts only before fertilization and will not affect an existing pregnancy.</answer>
<other>The FDA changed Plan B's label language to make it clear that it acts only before fertilization and will not work if already pregnant.</other>

<question_number>8</question_number>
<answer>N/A</answer>
<other>The article does not mention which pharmaceutical company funded the Mexico City portion of the study.</other>

<question_number>9</question_number>
<answer>N/A</answer>
<other>The article does not specify the optimal dosing interval between ulipristal acetate and misoprostol.</other>

<question_number>10</question_number>
<answer>Three</answer>
<other>The article mentions that the revived federal lawsuit against the FDA has three states as plaintiffs.</other>

<question_number>11</question_number>
<answer>60 milligrams</answer>
<other>The study used a 60 milligram dose of ulipristal acetate.</other>

<question_number>12</question_number>
<answer>N/A</answer>
<other>The article does not mention any legal action Students for Life of America would consider regarding the FDA-approved label change for Plan B One-Step.</other>

<question_number>13</question_number>
<answer>Ella's potential to act as an abortifacient</answer>
<other>Dr. Harrison's statement highlights ulipristal acetate's potential to end the life of an embryo.</other>

<question_number>14</question_number>
<answer>0%</answer>
<other>The study used a higher dose of ulipristal acetate, not the standard 30mg dose of Ella, for terminating pregnancies.</other>

<question_number>15</question_number>
<answer>N/A</answer>
<other>The article does not mention any specific medical use of misoprostol other than facilitating abortion in the context of the revived lawsuit.</other>

<question_number>16</question_number>
<answer>N/A</answer>
<other>The article does not specify any action taken by the Supreme Court regarding the revived lawsuit with three states as plaintiffs.</other>

<question_number>17</question_number>
<answer>Women on Web</answer>
<other>The telemedicine organization founded by Dr. Rebecca Gomperts is Women on Web.</other>

<question_number>18</question_number>
<answer>To stop or delay ovulation</answer>
<other>The FDA label for Ella states its likely primary mechanism of action is to stop or delay ovulation.</other>

<question_number>19</question_number>
<answer>Dr. Beverly Winikoff</answer>
<other>Dr. Beverly Winikoff is the lead author of the Gynuity Health Projects study.</other>

<question_number>20</question_number>
<answer>Progesterone</answer>
<other>Both mifepristone and the higher dose of ulipristal acetate block the hormone progesterone.</other>